Drug
Epoetin Alfa
Epoetin Alfa: highest development phase Phase 3, developed by Johnson & Johnson. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Epoetin alfa NCT00083434 | Phase 3 | Anemia |
| epoetin alfa NCT00270179 | Phase 3 | Anemia |
| epoetin alfa NCT00270088 | Phase 3 | Anemia |
| epoetin alfa NCT00270114 | Phase 2/3 | Anemia |
Latest
No recent events.
Follow Epoetin Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.